Arrowhead Pharmaceuticals, Inc. technical analysis
Technical analysis of Arrowhead Pharmaceuticals, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. is a U.S. pharmaceutical company founded in 2003 and headquartered in Pasadena, California, that develops RNAi-based medicines for the treatment of various diseases. The company's pipeline includes several clinical-stage candidates, such as Plozasiran and Zodasiran in Phase 3 studies, along with numerous other therapeutic programs in earlier development stages. The company collaborates with major international pharmaceutical partners including GlaxoSmithKline, Takeda, Amgen, and Sarepta Therapeutics.
Description generated automatically from public sources; it may be inaccurate or out of date.
Arrowhead Pharmaceuticals, Inc.: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
86.99 $
−0.75%
50 sessions
84.01 $
+2.77%
200 sessions
71.14 $
+21.37%
Session levels
s2
82.25
Support
s1
84.37
Support
pivot
85.58
Pivot
r1
87.70
Resistance
r2
88.91
Resistance
How to read it
In the September 4, 2026 session Arrowhead Pharmaceuticals, Inc. closed lower at 86.34 $, −0.17% versus the previous session.
The price sits mixed against its moving averages: −0.75% against the 21-session average, +2.77% against the 50 and +21.37% against the 200.
The 14-period RSI reads 51.5, in neutral territory.
MACD stands at 0.279 against a signal line at 0.752: the histogram is negative (−0.473).
ADX reads 16.8, indicating weak directionality.
Levels computed on the latest session place supports at 84.37 and 82.25 $ and resistances at 87.70 and 88.91 $, around a pivot of 85.58.
The average daily range (ATR) is 3.251 $, or 3.77% of price.
Turnover was 757.6K shares, 70% of the 20-session average.
Over the last twelve months the price ranged between 54.91 and 95.49 $, and today stands −9.58% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the ARWR analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Arrowhead Pharmaceuticals, Inc.
How is Arrowhead Pharmaceuticals, Inc. analysed technically?
Technical analysis of Arrowhead Pharmaceuticals, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Arrowhead Pharmaceuticals, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Arrowhead Pharmaceuticals, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Arrowhead Pharmaceuticals, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.